Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats

Chinese Journal of Physiology

Volumn 52, Issue 2, 2009, Pages 65-71

  Liu, Tse Tsung ^a   Shih, Kuang Chung ^b   Kao, Chung Cheng ^c   Cheng, Wei Tung ^d   Hsieh, Po Shiuan ^e  

^a HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cyclooxygenase 2 mediated inflammation; Fructose; Insulin resistance; Oxidative stress; Rats; Skeletal muscle

Indexed keywords

8 ISOPROSTANE; CELECOXIB; CYCLOOXYGENASE 2; DEOXYGLUCOSE; FRUCTOSE; GLUCOSE; INSULIN; NIMESULIDE; PROSTAGLANDIN E; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; SYSTOLIC BLOOD PRESSURE; TIME SERIES ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CYCLOOXYGENASE 2; DINOPROST; DISEASE MODELS, ANIMAL; FRUCTOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; PROSTAGLANDINS E; RATS; RATS, SPRAGUE-DAWLEY; SWEETENING AGENTS;

EID: 70349556356     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2009.AMH034     Document Type: Article

References (36)

1. Alpert, E., Gruzman, A., Tennenbaum, T. and Sasson, S. Selective cyclooxygenase-2 inhibitors stimulate glucose transport in L6 myotubes in a protein kinase Cδ-dependent manner. Biochem. Pharmacol. 73: 368-377, 2007.
2. Ariano, M.A., Armstrong, R.B. and Edgerton, V.R. Hindlimb muscle fiber populations of five mammals. J. Histochem. Cytochem. 21: 51-55, 1973.
3. Camps, M., Castello, A., Munoz, P., Monfar, M., Testar, X., Palacin, M. and Zorzano, A. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem. J. 282: 765-772, 1992.
4. Davi, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G. and Patrono, C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N. Engl. J. Med. 322: 1769-1774, 1990.
5. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
6. Duncan, B.B., Schmidt, M.I., Pankow, J.S., Ballantyne, C.M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A.R. and Heiss, G. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805, 2003.
7. El Midaoui, A., Wu, R. and de Champlain, J. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J. Hypertens. 20: 1407-1412, 2002.
8. Eriksson, J.W. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. FEBS Lett. 581: 3734-3742, 2007.
9. FitzGerald, G.A. and Patrono, C. The coxibs, selective inhibitors of cyclooxygenase-2. New Eng. J. Med. 345: 433-442, 2001.
10. Galipeau, D., Arikawa, E., Sekirov, I. and McNeill, J.H. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 38: 872-876, 2001.
11. Gonzalez-Ortiz, M., Martinez-Abundis, E., Balcazar-Munoz, B.R. and Robles-Cervantes, J.A. Inhibition of cyclooxygenase-1 or -2 on insulin sensitivity in healthy subjects. Horm. Metab. Res. 33: 250-253, 2001.
12. Hansen, P.A., Gulve, E.A. and Holloszy, J.O. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J. Appl. Physiol. 76: 979-985, 1994.
13. Helmersson, J., Vessby, B., Larsson, A. and Basu, S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109: 1729-1734, 2004.
14. Henriksen, E.J., Bourey, R.E., Rodnick, K.J., Koranyi, L., Permutt, M.A. and Holloszy, J.O. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am. J. Physiol. 259: E593-E598, 1990.
15. Hermann, M., Camici, G., Fratton, A., Hurlimann, D., Tanner, F.C., Hellermann, J.P., Fiedler, M., Thiery, J., Neidhart, M., Gay, R.E., Gay, S., Luscher, T.F. and Ruschitzka, F. Differential efects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 108: 2308-2311, 2003.
16. Hsieh, P.S., Cheng, W.T., Liu, T.T., Loh, C.H. and Chang, B.C. Diminution of hypertriglyceridemia-induced pressor effect under hyperinsulinemic condition in normal and fructose-induced insulin resistant rats. Chinese J. Physiol. 50: 99-104, 2007.
17. Hsieh, P.S. Attenuation of insulin-mediated pressor effect and nitric oxide release in rats with fructose-induced insulin resistance. Am. J. Hypertens. 17: 707-711, 2004.
18. Hsieh, P.S. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. J. Hypertens. 23: 2209-2217, 2005.
19. Huang, Y., Liu, J., Wang, L-Z., Zhang, W.-Y. and Zhu, X.-Z. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Acta Pharmacol. Sin. 26: 952-958, 2005.
20. Hundal, R.S., Petersen, K.F., Mayerson, A.B., Randhawa, P.S., Inzucchi, S., Shoelson, S.E. and Shulman, G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109: 1321-1326, 2002.
21. Kern, M., Wells, J.A,, Stephens, J.M., Elton, C.W., Friedman, J.E., Tapscott, E.B., Pekala, P.H. and Dohm, G.L. Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem. J. 270: 397-400, 1990.
22. Konheim, Y.L. and Wolford, J.K. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum. Genet. 113: 377-381, 2003.
23. McAdam, B.F., Catella-Lawson, F., Mardini, I.A., Kapoor, S., Lawson, J.A. and FitzGerald, GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. U.S.A. 96: 272-277, 1999.
24. Meszaros, K., Lang, C.H., Bagby, G.J. and Spitzer, J.J. Contribution of different organs to increased glucose consumption after endotoxin administration. J. Biol. Chem. 262: 10965-10970, 1987.
25. Miller, A., Adeli, K., Miller, A. and Adeli, K. Dietary fructose and the metabolic syndrome. Curr. Opin. Gastroenterol. 24: 204-209, 2008.
26. Perucca, E. Drug interactions with nimesulide. Drugs 46 Suppl 1: 79-82, 1993.
27. Pitt, B., Pepine, C. and Willerson, J.T. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation 106: 167-169, 2002.
28. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. [see comment]. J. Am. Med. Assoc. 286: 327-334, 2001.
29. Rutledge, A.C., Adeli, K., Rutledge, A.C. and Adeli, K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr. Rev. 65: S13-S23, 2007.
30. Schmidt, M.I. and Duncan, B.B. Diabesity: an inflammatory metabolic condition. Clin. Chem. Lab. Med. 41: 1120-1130, 2003.
31. Smith, C.J., Zhang, Y., Koboldt, C.M., Muhammad, J., Zweifel, B.S., Shaffer, A., Talley, J.J., Masferrer, J.L., Seibert, K. and Isakson, P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U.S.A. 95: 13313-13318, 1998.
32. Sone, H., Takahashi, A. and Yamada, N. Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea. Ann. Intern. Med. 134: 344, 2001.
33. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A. and Salvetti, A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
34. Whelton, A., Schulman, G., Wallemark, C., Drower, E.J., Isakson, P.C., Verburg, K.M. and Geis, G.S. Effects of celecoxib and naproxen on renal function in the elderly. Arch. Intern. Med. 160: 1465-1470, 2000.
35. Whittington, K.B., Solomon, S.S., Lu, Z.N. and Selawry, H.P. Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine. Endocrinology 128: 2671-2677, 1991.
36. Young, D.A., Uhl, J.J., Cartee, G.D. and Holloszy, J.O. Activation of glucose transport in muscle by prolonged exposure to insulin. Effects of glucose and insulin concentrations. J. Biol. Chem. 261: 16049-16053, 1986.